Blueprint for transparency at the U.S. food and drug administration: Recommendations to advance the development of safe and effective medical products

Sharfstein, J. M., Miller, J. D., Davis, A. L., Ross, J. S., McCarthy, M. E., Smith, B., … Kesselheim, A. S. (2017). Blueprint for transparency at the U.S. food and drug administration: Recommendations to advance the development of safe and effective medical products. Journal of Law, Medicine and Ethics, 45(2_suppl), 7–23. https://doi.org/10.1177/1073110517750615